4104 — Excelsior Medical Co Cashflow Statement
0.000.00%
Last trade - 00:00- TWD14.60bn
- TWD15.75bn
- TWD8.79bn
Annual cashflow statement for Excelsior Medical Co, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 874 | 964 | 1,144 | 1,174 | 1,182 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -241 | -309 | -430 | -400 | -452 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 110 | -240 | -872 | 1,396 | -2,407 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 945 | 637 | 107 | 2,471 | -1,364 |
| Capital Expenditures | -169 | -173 | -143 | -121 | -83 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 313 | -518 | 248 | 55.1 | 308 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Change in Net Intangibles | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 144 | -690 | 106 | -65.6 | 225 |
| Financing Cash Flow Items | -95.7 | -112 | -65.6 | -46 | -166 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -594 | -634 | -105 | -956 | -149 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 454 | -565 | 108 | 1,574 | -1,342 |